+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Molecular Diagnostics for Infectious Disease - Market Forecasts, Strategies and Trends - By Syndrome and by Country - With Multiplex and Point of Care Market Analysis, Executive Guides and Customization 2020 to 2024

  • ID: 4662828
  • Report
  • November 2020
  • Region: Global
  • 425 Pages
  • Howe Sound Research
Multiplex Testing Threatens Existing Assays. Test Speed Taking Centre Stage.

FEATURED COMPANIES

  • Abbott Diagnostics
  • BD Diagnostics
  • DiagenodeDiagnostics
  • Hologic
  • Meridian Bioscience
  • Quantumdx
  • MORE

Multiplex testing threatens existing infectious disease practice. The microbiology lab may disappear.

The Molecular Diagnostics – Infectious Disease sector of the clinical diagnostics industry is poised for record growth. 

A market that just keeps on growing.  In spite of the steady decline of disease prevalence, the diagnostic sector keeps growing. Find out why in the informative report. And find out about the exciting developments in multiplex assays which threaten to change diagnosis and treatment while limiting the threat of anti microbial drug resistance.

Infectious disease testing directly benefits from the explosion in biotechnology, especially genomics. 

Learn all about it in this new report. A range of dynamic trends are pushing market growth and company valuations.

Trends like:

  • Multiplex testing
  • emerging economies and global prosperity
  • biotechnology advances in genetics
  • pathogen evolution
  • climate change
  • globalization
  • the rise of rapid testing

Exciting technical developments especially in the seesaw between sequencing and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication.

The report has hundreds of pages of information including a complete list of Current 2016 United States Medicare Fee Payment Schedules to help sharpen your pricing. Again, assistance in using the information is normally provided without additional charges. 

The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Diagnostics
  • BD Diagnostics
  • DiagenodeDiagnostics
  • Hologic
  • Meridian Bioscience
  • Quantumdx
  • MORE

1. Introduction and Market Definition
1.1 What is Molecular Diagnostics
1.2 The Diagnostics Revolution
1.3 Market Definition
1.3.1 Volumes
1.3.2 Prices
1.3.3 Revenue Market Size
1.4 Methodology
1.4.1 Authors
1.4.2 Sources
1.5 U.S. Medical Market and Clinical Laboratory Testing - Perspective
1.5.1 U.S. Medicare Expenditures for Clinical Testing

2. The Infectious Diseases – Market Analysis by Disease
2.1 HIV - Human Immunodeficiency Virus (AIDS)
2.1.1 Virology
2.1.1.1 Classification
2.1.1.2 Structure and genome
2.1.1.3 Tropism
2.1.1.4 Replication cycle
2.1.1.5 Genetic variability
2.1.2 Diagnosis
2.1.3 Testing
2.1.3.1 Antibody tests
2.1.3.2 Point of Care Tests (POCT)
2.1.3.3 Antigen Tests
2.1.3.4 Nucleic acid-based tests (NAT)
2.1.3.5 Other tests used in HIV treatment
2.1.4 Market Opportunity Analysis
2.2 HBV – Hepatitis B
2.2.1 Virology
2.2.1.1 Genome
2.2.1.2 Pathogenesis
2.2.1.3 Hepatitis B virus replication
2.2.1.4 Serotypes and genotypes
2.2.2 Mechanisms
2.2.3 Diagnosis
2.2.4 Market Opportunity Analysis
2.3 HCV – Hepatitis C
2.3.1 Taxonomy
2.3.2 Structure
2.3.2.2 Genome
2.3.3 Molecular biology
2.3.4 Replication
2.3.5 Genotypes
2.3.5.1 Clinical importance
2.3.6 Market Opportunity Analysis
2.4 HPV - Human papillomavirus
2.4.1 Virology
2.4.1.1 E6/E7 proteins
2.4.1.2 Role in cancer
2.4.1.3 E2 research
2.4.1.4 Latency period
2.4.1.5 Clearance
2.4.2 Diagnosis
2.4.2.1 Cervical testing
2.4.2.2 Oral testing
2.4.2.3 Testing men
2.4.2.4 Other testing
2.4.3 Market Opportunity Analysis
2.5 Influenza
2.5.1 Virology
2.5.1.1 Types of virus
2.5.1.2 Influenzavirus A
2.5.1.3 Influenzavirus B
2.5.1.4 Influenzavirus C
2.5.1.5 Structure, properties, and subtype nomenclature
2.5.1.6 Replication
2.5.2 Testing
2.5.2.1 Advantages/Disadvantages of Molecular Assays
2.5.3 Market Opportunity Analysis
2.6 CTGC - Chlamydia/Gonorhea
2.6.1 Gonorrhea
2.6.1.1 Diagnosis
2.6.1.2 Screening
2.6.2 Chlamydia
2.6.2.1 Diagnosis
2.6.2.2 Screening
2.6.3 Testing
2.6.3.1 Nucleic acid amplification tests (NAATs).
2.6.3.2 Performance of NAAT Tests
2.6.4 Market Opportunity Analysis
2.7 Tuberculosis
2.7.1 Mycobacteria
2.7.2 Diagnosis
2.7.2.1 Active tuberculosis
2.7.2.2 Latent tuberculosis
2.7.3 Epidemiology
2.7.4 Molecular Diagnostic Tests
2.7.5 Market Opportunity Analysis
2.8 MRSA - Methicillin-resistant Staphylococcus aureus
2.8.1 Diagnosis
2.8.2 FDA Approved Molecular Tests
2.8.3 Market Opportunity Analysis
2.9 VRE - Vancomycin-resistant Enterococcus
2.9.1 FDA Approved MDx Tests for VRE
2.9.2 Market Opportunity Analysis
2.10 Blood Screening
2.10.1 Collection and Testing
2.10.2 FDA Approved Multiplex Assays
2.10.3 Market Opportunity Analysis

3. Industry Overview
3.1 Industry Participants
3.1.1 IVD Supplier
3.1.2 Independent lab specialized/esoteric
3.1.3 Independent lab national/regional
3.1.4 Independent lab analytical
3.1.5 Public National/regional lab
3.1.6 Hospital lab
3.1.7 Physician lab
3.1.8 Audit body
3.2 The Clinical Laboratory Market Segments
3.2.1 Traditional Market Segmentation
3.2.2 Laboratory Focus and Segmentation
3.3 Industry Structure
3.3.1 Hospital Testing Share
3.3.2 Economies of Scale
3.3.2.1 Hospital vs. Central Lab
3.3.3 Physician Office Lab’s
3.3.4 Physician’s and POCT
3.4 Profiles of Key MDx Companies
Abbott Diagnostics
Accelerate Diagnostics
Ador Diagnostics
Akonni Biosystems
Alveo Technologies
Applied BioCode
Atlas Genetics
Aus Diagnostics
BD Diagnostics
Beckman Coulter
Biocartis
bioMérieux
Bio-Rad Laboratories
Bosch Healthcare Solutions GmbH
Cepheid
Chembio
Curetis
DiagenodeDiagnostics
DiaSorin
Eiken Chemical
Fusion Genomics
Genedrive
GenePOC Diagnostics
GenMark Dx
Grifols
Hologic
Illumina
Inflammatix
Janssen Diagnostics
Karius
Lexagene
Luminex
Mbio Diagnostics
Meridian Bioscience
Mesa Biotech
Mobidiag
Nanomix
Oxford Nanopore Technologies
Panagene
Primerdesign
Prominex
Qiagen
Quantumdx
Quidel
Roche Molecular Diagnostics
Seegene
Siemens Healthineers
T2 Biosystems
Thermo Fisher
Veramarx
XCR Diagnostics

4. Market Trends
4.1 Factors Driving Growth
4.1.1 New Genotypes Creating New Markets
4.1.2 Aging Population a Boon for All Diagnostics
4.1.3 Developing World Driving ID Dx Growth
4.1.4 Point of Care – Why Centralization is Losing Steam
4.1.5 Self Testing
4.1.6 The Need for Speed
4.2 Factors Limiting Growth
4.2.1 Lower Costs
4.2.2 Infectious Disease is Declining
4.2.3 Wellness Hurts
4.2.4 Economic Growth improves Living Standards
4.3 Instrumentation and Automation
4.3.1 Instruments Key to Market Share
4.3.2 The Shrinking Machine.
4.3.2 Multiplex, Point of Care and The Speed Factor
4.4 Diagnostic Technology Development
4.4.1 The Sepsis Testing Market – A New Direction?
4.4.2 POCT/Self Testing as a Disruptive Force
4.4.3 The Genetics Play – One Test for All Known Infections
4.4.4 Antibiotic Resistance Genes – Simplifying Diagnostics

5. Molecular Dx – Infectious Disease Recent Developments

  • Recent Developments– Importance and How to Use This Section
  • Importance of These Developments
  • How to Use This Section
  • Fusion Genomics to Assess NGS-Based Respiratory Tract Infection Assay
  • New Genomic Tests Diagnose Deadly Infections Faster
  • Biotia Raises $2.4M Seed Round
  • STDs resurge in US
  • Ares Genetics signs R&D agreement with leading global IVD corporation
  • Cell-Free DNA Used for Infectious Disease Testing
  • One BioMed Raises $5M
  • FDA grants Qiagen clearance for syndromic testing system
  • iCubate, Wondfo Biotech Form Chinese JV to Develop MDx Assays
  • Researchers Launch CRISPR Dx Firm Sherlock Biosciences
  • Israel's BATM to Invest up to $30M in Ador Diagnostics
  • Superbug Test from Mobidiag Gets CE Mark
  • Akonni Biosystems Submits Multiplex Diagnostics System to FDA
  • Mesa Biotech RSV Test Wins CE Mark
  • Karius Test to Be Available in Brazil
  • Panagene’s STD kit gains Approval
  • Startup Prominex Raises $4M in Series A
  • GenePOC's Investment Validated by Medicare Decision
  • GenePOC® launches its GenePOC® CDiff test in Canada
  • NYU researchers adapt HIV test to Zika virus
  • GA-EMS receives diagnostic device contract
  • Biocartis & Immunexpress Sign Partnership for Sepsis
  • PerkinElmer to Acquire Euroimmun for $1.3B
  • Alveo Closes Financing to Create Accessible Diagnostics Devices
  • Siemens Healthineers completes takeover of Fast Track Diagnostics
  • Sekisui Diagnostics Enters Strategic Alliance with Mesa Biotech Inc
  • Chembio and FIND to Develop Point-of-Care Multiplex Test
  • Locus Biosciences and IDbyDNA Partner to Develop Companion Diagnostic Test
  • Alere bags FDA nod for rapid flu diagnostic
  • FDA approves tests of tick-borne disease to protect blood supply
  • Qiagen Trichomonas Assay Gets CE Mark
  • Vela Diagnostics HSV Test Gets FDA Clearance
  • QIAGEN enters into an agreement to acquire STAT-Dx
  • Bruker to Acquire Majority Stake in Infectious Disease MDx Firm Hain
  • Applied BioCode’s Syndromic Gastrointestinal Pathogen Panel Approved by the FDA
  • Ares Genetics to develop AI diagnostic test for infectious diseases
  • FDA Considers Guidelines for NGS-Based Infectious Disease Diagnostics

6. The Global Market for Molecular Diagnostics Infectious Disease
6.1 Global Market Overview by Country
6.1.1 Table–Global Market by Country
6.1.2 Chart-Global Market by Country
6.2 Global Market by Syndrome-Overview
6.2.1 Table–Global Market by Syndrome
6.2.2 Chart–Global Market by Syndrome–2019/2024 Comparison
6.2.3 Chart–Global Market by Syndrome–2019
6.2.4 Chart–Global Market by Syndrome–2024
6.2.5 Chart–Global Market by Syndrome–Share by Year

7. Global Molecular Diagnostics Infectious Disease Markets–By Syndrome
7.1 Respiratory
7.1.1 Table Respiratory–by Country
7.1.2 Chart-Respiratory Growth
7.2 Gastrointestinal
7.2.1 Table Gastrointestinal –by Country
7.2.2 Chart-Gastrointestinal Growth
7.3 Blood
7.3.1 Table Blood–by Country
7.3.2 Chart-Blood Growth
7.4 Meningitis/Encephalitis
7.4.1 Table Meningitis/Encephalitis–by Country
7.4.2 Chart-Meningitis/Encephalitis Growth
7.5 Sexually Transmitted Disease
7.5.1 Table Sexually Transmitted Disease–by Country
7.5.2 Chart–Sexually Transmitted Disease Growth
7.6 Other
7.6.1 Table Other–by Country
7.6.2 Chart-Other Growth

Appendices
I. United States Medicare System: 2019 Clinical Laboratory Fees Schedule
II. FDA Approved Human Genetic Tests
III. FDA Approved Microbial Tests
III. FDA Approved Pharmacogenomics Tests

Table of Tables
Table 1 Medicare Clinical Lab Expenditures Actual & Forecast 2014 to 2024 ($Billion)
Table 2 Classification of HIV Species
Table 3 HIV Tests-CMS Codes & Prices
Table 4 Current HIV Molecular Tests and Instruments Used
Table 5 HBV Tests-CMS Codes & Prices
Table 6 HCV Tests-CMS Codes & Prices
Table 7 HPV Clearance Rates
Table 8 HPV Tests-CMS Codes & Prices
Table 9 HPV Tests, Technology, Types
Table 10 Types of Influenza Tests
Table 11 Influenza Tests-CMS Codes & Prices
Table 12 FDA Cleared Molecular Assays for Influenza
Table 13 FDA Cleared NAAT CTGC Tests
Table 14 CTGC NAAT Target Sequences and Possible False Reactions
Table 15 CTGC Tests-CMS Codes & Prices
Table 16 FDA Approved MDx Tests for Tuberculosis
Table 17 Tuberculosis Tests-CMS Codes & Prices
Table 18 FDA Approved Tests for MRSA
Table 19 MRSA Tests-CMS Codes & Prices
Table 20 FDA Approved Tests for VRE
Table 21 VRE Tests-CMS Codes & Prices
Table 22 FDA Approved Multiplex Assays
Table 23 Market Players by Type
Table 24 Clinical Laboratory Departments and Segments
Table 25 Laboratory Management Focus–Different Approaches
Table 26 Key Segmentation Variables Going Forward
Table 27 Five Factors Driving Growth
Table 28 Four Factors Limiting Growth
Table 29 Key Diagnostic Laboratory Technology Trends
Table 30 Global Market by Region
Table 31 Global Market by Syndrome
Table 32 Respiratory by Country
Table 33 Gastrointestinal by Country
Table 34 Blood by Country
Table 35 Meningitis/Encephalitis by Country
Table 36 Sexually Transmitted Disease by Country
Table 37 Other by Country
Table 38 2019 Clinical Lab Fee Schedule
Table 39 FDA Approved Human Genetic Tests
Table 40 FDA Approved Microbial Tests

Table of Figures
Figure 1 Medicare Clinical Lab Expenditures 2014 to 2024 ($Million)
Figure 2 HIV Virion
Figure 3 Diagram of the HIV Replication Cycle
Figure 4 The Structure of the HBV Virus
Figure 5 Hepatitis B Replication
Figure 6 Structure of the HCV Virus
Figure 7 HCV Replication Cycle
Figure 8 Structure of the Influenza Virion
Figure 9 Influenza Replication
Figure 10 Scanning Electronmicrograph of Tuberculosis
Figure 11 Percentage of World Population Over 65
Figure 12 Chart Infectious Disease Decline
Figure 13 2019 Global Market Density Chart
Figure 14 Global Market by Syndrome-2019 vs. 2024
Figure 15 Global Market by Syndrome 2019
Figure 16 Global Market by Syndrome 2024
Figure 17 Syndrome Share by Year
Figure 18 Respiratory Growth
Figure 19 Gastrointestinal Diagnostics Growth
Figure 20 Blood Growth
Figure 21 Meningitis/EncephalitisGrowth
Figure 22 Sexually Transmitted Disease Growth
Figure 23 Other Growth

Note: Product cover images may vary from those shown
  • Abbott Diagnostics
  • Accelerate Diagnostics
  • Ador Diagnostics
  • Akonni Biosystems
  • Alveo Technologies
  • Applied BioCode
  • Atlas Genetics
  • Aus Diagnostics
  • BD Diagnostics
  • Beckman Coulter
  • Biocartis
  • bioMérieux
  • Bio-Rad Laboratories
  • Bosch Healthcare Solutions GmbH
  • Cepheid
  • Chembio
  • Curetis
  • DiagenodeDiagnostics
  • DiaSorin
  • Eiken Chemical
  • Fusion Genomics
  • Genedrive
  • GenePOC Diagnostics
  • GenMark Dx
  • Grifols
  • Hologic
  • Illumina
  • Inflammatix
  • Janssen Diagnostics
  • Karius
  • Lexagene
  • Luminex
  • Mbio Diagnostics
  • Meridian Bioscience
  • Mesa Biotech
  • Mobidiag
  • Nanomix
  • Oxford Nanopore Technologies
  • Panagene
  • Primerdesign
  • Prominex
  • Qiagen
  • Quantumdx
  • Quidel
  • Roche Molecular Diagnostics
  • Seegene
  • Siemens Healthineers
  • T2 Biosystems
  • Thermo Fisher
  • Veramarx
  • XCR Diagnostics
Note: Product cover images may vary from those shown
Adroll
adroll